BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2208712)

  • 41. ELISA for the measurement of serum and urinary chorionic gonadotropin concentrations in the laboratory macaque.
    Munro CJ; Laughlin LS; Illera JC; Dieter J; Hendrickx AG; Lasley BL
    Am J Primatol; 1997; 41(4):307-22. PubMed ID: 9093694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of Result Times Between Urine and Whole Blood Point-of-care Pregnancy Testing.
    Gottlieb M; Wnek K; Moskoff J; Christian E; Bailitz J
    West J Emerg Med; 2016 Jul; 17(4):449-53. PubMed ID: 27429695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An enzyme immunoassay to determine human chorionic gonadotropin (HCG) in serum and urine samples using an ultra-microanalytical system.
    Del Valle García R; Cazanave Mora JM; Carrazana San Martín NL; Zulueta Rodríguez O; Melchor Rodríguez A; Hernández Pérez L; López Cisneros R; Lorenzo Rojas A; Gato Orozco ED; Benítez Gordillo D; González Quintero A; García de la Rosa I; Coto Rodeiro R
    J Pharm Biomed Anal; 2021 Sep; 204():114239. PubMed ID: 34252818
    [TBL] [Abstract][Full Text] [Related]  

  • 44. False-negative results in point-of-care qualitative human chorionic gonadotropin (hCG) devices due to excess hCGbeta core fragment.
    Gronowski AM; Cervinski M; Stenman UH; Woodworth A; Ashby L; Scott MG
    Clin Chem; 2009 Jul; 55(7):1389-94. PubMed ID: 19395437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Five recent urinary tests for early pregnancy evaluated.
    Ryder KW; Munsick RA; Oei TO; Young PC; Blackford HF
    Clin Chem; 1983 Oct; 29(10):1812-4. PubMed ID: 6616829
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Limitations in qualitative point of care hCG tests for detecting early pregnancy.
    Greene DN; Schmidt RL; Kamer SM; Grenache DG; Hoke C; Lorey TS
    Clin Chim Acta; 2013 Jan; 415():317-21. PubMed ID: 23159297
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An algorithm for testing and reporting serum choriogonadotropin at clinically significant decision levels with use of "pregnancy test" reagents.
    Bandi ZL; Schoen I; Waters M
    Clin Chem; 1989 Apr; 35(4):545-51. PubMed ID: 2649272
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The value of a single sensitive urine pregnancy test in prediction of pregnancy outcome.
    Chan YF; So WW; Yeung WS; Lau EY; Ho PC
    Asia Oceania J Obstet Gynaecol; 1994 Dec; 20(4):401-5. PubMed ID: 7832673
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: A new basis for gestational Down syndrome screening.
    Cole LA; Shahabi S; Oz UA; Bahado-Singh RO; Mahoney MJ
    Clin Chem; 1999 Dec; 45(12):2109-19. PubMed ID: 10585342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A single serum test for measuring early pregnancy outcome with high predictive value.
    Sutton-Riley JM; Khanlian SA; Byrn FW; Cole LA
    Clin Biochem; 2006 Jul; 39(7):682-7. PubMed ID: 16765931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Significance of pregnancy test false negative results due to elevated levels of β-core fragment hCG.
    Johnson S; Eapen S; Smith P; Warren G; Zinaman M
    J Immunoassay Immunochem; 2017; 38(4):449-455. PubMed ID: 28521601
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pregnancy tests: a review.
    Chard T
    Hum Reprod; 1992 May; 7(5):701-10. PubMed ID: 1639991
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human chorionic gonadotropin in pregnancy diagnostics.
    Montagnana M; Trenti T; Aloe R; Cervellin G; Lippi G
    Clin Chim Acta; 2011 Aug; 412(17-18):1515-20. PubMed ID: 21635878
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitative urine hCG and urine pregnancy test in gestational trophoblastic disease patients with low hCG titer.
    Lertkhachonsuk R
    J Med Assoc Thai; 2015 Jan; 98 Suppl 1():S36-41. PubMed ID: 25764611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pregnancy serum contains the beta-core fragment of human choriogonadotropin.
    Alfthan H; Stenman UH
    J Clin Endocrinol Metab; 1990 Mar; 70(3):783-7. PubMed ID: 1689741
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of low urine specific gravity on pregnancy testing.
    Neinstein L; Harvey F
    J Am Coll Health; 1998 Nov; 47(3):138-9. PubMed ID: 9830821
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Automated quantification of choriogonadotropin: analytical correlation between serum and urine with creatinine correction.
    Wu AH; Wong SS; Waldron C; Chan DW
    Clin Chem; 1987 Aug; 33(8):1424-6. PubMed ID: 3038377
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the performance of serum and urine hCG immunoassays in the evaluation of gynecologic patients.
    Naryshkin S; Aw TC; Filstein M; Murphy JG; Strauss JF; Kiechle FL; Jacobson S
    Ann Emerg Med; 1985 Nov; 14(11):1074-6. PubMed ID: 4051272
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of five kits for detecting choriogonadotropin in urine.
    Sheehan C; Carreiro E
    Clin Chem; 1985 Jun; 31(6):875-6. PubMed ID: 3995767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disparity between beta-core levels in pregnancy urine and serum: implications for the origin of urinary beta-core.
    Wehmann RE; Blithe DL; Akar AH; Nisula BC
    J Clin Endocrinol Metab; 1990 Feb; 70(2):371-8. PubMed ID: 1688864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.